BIOFILCHEM2023-07-012023-09-30 BIOFILCHEM2023-07-012023-09-30 BIOFILCHEM2023-07-012023-09-30in-bse-fin:OneOperatingExpenses01Member BIOFILCHEM2023-07-012023-09-30in-bse-fin:OneOperatingExpenses02Member BIOFILCHEM2023-07-012023-09-30in-bse-fin:OneOperatingExpenses03Member BIOFILCHEM2023-07-012023-09-30in-bse-fin:FourOperatingExpenses01Member BIOFILCHEM2023-07-012023-09-30in-bse-fin:FourOperatingExpenses02Member BIOFILCHEM2023-07-012023-09-30in-bse-fin:FourOperatingExpenses03Member BIOFILCHEM2023-09-30 BIOFILCHEM2023-07-012023-09-30in-bse-fin:OneReportableSegmentRevenue01Member BIOFILCHEM2023-07-012023-09-30in-bse-fin:OneReportableSegmentRevenue02Member BIOFILCHEM2023-07-012023-09-30in-bse-fin:FourReportableSegmentRevenue01Member BIOFILCHEM2023-07-012023-09-30in-bse-fin:FourReportableSegmentRevenue02Member BIOFILCHEM2023-07-012023-09-30in-bse-fin:OneReportableSegmentResults01Member BIOFILCHEM2023-07-012023-09-30in-bse-fin:OneReportableSegmentResults02Member BIOFILCHEM2023-07-012023-09-30in-bse-fin:FourReportableSegmentResults01Member BIOFILCHEM2023-07-012023-09-30in-bse-fin:FourReportableSegmentResults02Member BIOFILCHEM2023-07-012023-09-30in-bse-fin:OneReportableSegmentAssets01Member BIOFILCHEM2023-07-012023-09-30in-bse-fin:OneReportableSegmentAssets02Member BIOFILCHEM2023-07-012023-09-30in-bse-fin:OneReportableSegmentLiabilities01Member BIOFILCHEM2023-09-30in-bse-fin:OneReportableSegmentLiabilities01Member BIOFILCHEM2023-07-012023-09-30in-bse-fin:OneReportableSegmentLiabilities02Member BIOFILCHEM2023-09-30in-bse-fin:OneReportableSegmentLiabilities02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 524396 BIOFILCHEM NOTLISTED Biofil Chemicals & Pharmaceuticals Limited Equity 2023-04-01 2024-03-31 2023-11-09 2023-11-01 INR Lakhs Half yearly 18:00:00 19:15:00 2023-11-09 2023-11-09 true Cash Flow Indirect Not applicable Multi segment 2023-07-01 2023-09-30 Unaudited Standalone 173676000.00 315000.00 173991000.00 129224000.00 70881000.00 -33098000.00 1628000.00 97000.00 1073000.00 2657000.00 172462000.00 1529000.00 0.00 1529000.00 300000.00 0.00 300000.00 0.00 1229000.00 0.00 0.00 0.00 0.00 1229000.00 0.00 1229000.00 0.00 0.00 162738000.00 10 0.08 0.08 0.00 0.00 0.08 0.08 1. The above unaudited results for the Quarter and half year ended Sept. 30, 2023 were reviewed and recommended by the Audit Committee and approved by the Board of Directors in it's meeting held on November 09, 2023. The above results have been reviewed by statutory Auditors of the company in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, who have expressed an unmodified opinion. The Company's Management has exercised necessary due diligence to ensure that the financial results provide a true and fair view of its affairs. 2. This statement has been prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015 (Ind AS) prescribed under Section 133 of the Companies Act, 2013 and other recognized accounting practices and policies to the extent applicable. 3. The Company has reported segment wise information as per Indian Accounting Standard (Ind AS-108). The Operations of the Company are conducted within India, there is no separate reportable geographical segment and the company reported the following business segments a. Pharma Division b. Chemicals Division. 4. The figures of the previous period / year have been re-stated/ re-grouped / re-arranged/ reclassified and / or recasted wherever found necessary. 5. The aforesaid un-audited financial Results will be uploaded on the Company’s website www.biofilgroup.net and will also be available on the websites of the Stock exchanges i.e. www.bseindia.com and www.nseindia.com for the benefit of shareholders and investors. Multi segment 2023-04-01 2023-09-30 Unaudited Standalone 198011000.00 562000.00 198573000.00 142775000.00 78931000.00 -38595000.00 3234000.00 206000.00 2147000.00 5105000.00 193803000.00 4770000.00 0.00 4770000.00 1100000.00 0.00 1100000.00 0.00 3670000.00 0.00 0.00 0.00 0.00 3670000.00 0.00 3670000.00 0.00 0.00 162738000.00 10 0.23 0.23 0.00 0.00 0.23 0.23 Administrative Expenses 943000.00 Manufacturing Expenses 1595000.00 Selling and Distribution Expenses 119000.00 Administrative Expenses 2107000.00 Manufacturing Expenses 2787000.00 Selling and Distribution Expenses 211000.00 87861000.00 0.00 0.00 0.00 0.00 0.00 87861000.00 50730000.00 0.00 273981000.00 345000.00 230000.00 0.00 274556000.00 9015000.00 334301000.00 422162000.00 162738000.00 13966000.00 176704000.00 176704000.00 0.00 0.00 0.00 3787000.00 3787000.00 5640000.00 232882000.00 238522000.00 1100000.00 2049000.00 241671000.00 245458000.00 422162000.00 Chemicals Division 72607000.00 Pharma Unit 101069000.00 Chemicals Division 88752000.00 Pharma Unit 109259000.00 173676000.00 198011000.00 173676000.00 198011000.00 Chemicals Division 1697000.00 Pharma Unit -88000.00 Chemicals Division 6746000.00 Pharma Unit -1793000.00 1609000.00 4953000.00 80000.00 182000.00 0.00 0.00 1529000.00 4771000.00 Chemicals Division 223735000.00 Pharma Unit 192806000.00 416541000.00 Chemicals Division 83085000.00 Pharma Unit 156753000.00 239838000.00 2147000.00 -38595000.00 -68954000.00 0.00 -2504000.00 0.00 0.00 0.00 0.00 106383000.00 0.00 -727000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 207000.00 0.00 0.00 -2043000.00 2727000.00 0.00 0.00 0.00 2740000.00 0.00 -13000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 416000.00 0.00 0.00 0.00 0.00 204000.00 0.00 0.00 212000.00 199000.00 0.00 199000.00 376000.00 575000.00 0.00 0.00 0.00 0.00